Can Celebrex (celecoxib) capsules be opened for administration through a feeding tube?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 13, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Celebrex Capsules Be Opened for Feeding Tube Administration?

Yes, Celebrex (celecoxib) capsules can be opened and the contents administered through a feeding tube, as the FDA label explicitly confirms that systemic exposure remains equivalent when capsule contents are sprinkled on applesauce compared to intact capsules, with no significant alterations in pharmacokinetics. 1

Key Evidence from FDA Drug Label

The FDA prescribing information for Celebrex provides direct guidance on this question. In healthy adult volunteers, the overall systemic exposure (AUC) of celecoxib was equivalent when administered as an intact capsule or when capsule contents were sprinkled on applesauce, with no significant alterations in Cmax, Tmax, or half-life. 1 This bioequivalence study specifically validates opening the capsules without compromising drug absorption or efficacy.

Practical Administration Guidelines

When administering celecoxib through a feeding tube, follow these evidence-based protocols from ESPEN guidelines 2:

  • Flush the tube with 30 mL of water before drug administration
  • Administer celecoxib individually (never mix with other medications)
  • Flush with 30 mL of water after administration
  • Use appropriate ENFit syringes to prevent misconnection errors 2

The capsule contents can be mixed with a small amount of water and administered immediately through the tube. Unlike extended-release formulations that must remain intact, celecoxib capsules contain drug powder without special coating that would be compromised by opening.

Important Pharmacokinetic Considerations

Celecoxib absorption is enhanced by food (10-20% increase in AUC), with peak levels delayed 1-2 hours when taken with high-fat meals 1. For doses up to 200 mg twice daily, timing relative to tube feeds is not critical. However, higher doses (400 mg twice daily) should be administered with food/tube feeds to improve absorption. 1

The drug has low aqueous solubility, which is why dissolution can be rate-limiting for absorption from solid dosage forms 3. Fortunately, celecoxib is a highly permeable drug that can be absorbed throughout the GI tract (stomach, duodenum, jejunum, and colon), making it suitable for administration regardless of feeding tube tip location 3.

Safety Profile for Tube Administration

Research on similar capsule formulations supports this practice. A 2024 study on tamsulosin capsules (another medication typically advised to be swallowed whole) found that opening capsules for enteral tube administration resulted in only 3.64% tube obstruction rate when content integrity was maintained 4.

Celecoxib suspensions have demonstrated excellent stability (93 days at both refrigerated and room temperature) 5, suggesting the drug itself is not prone to causing tube occlusions when properly prepared and administered.

Critical Precautions

While opening the capsules is safe from a pharmacokinetic standpoint, remember these essential safety considerations:

  • Stop tube feeds temporarily if administering phenytoin, carbamazepine, warfarin, or fluoroquinolones due to drug-nutrient interactions 6
  • Celecoxib does not interact with enteral formulas in the same problematic way as phenytoin 2, 7
  • Consult a pharmacist for patients on multiple medications to assess for drug-drug interactions 2
  • Monitor for NSAID-related adverse effects including cardiovascular events, GI bleeding, and renal dysfunction, particularly in elderly patients or those with pre-existing conditions 8, 9

Tube Patency Maintenance

To prevent tube occlusion 2:

  • Never mix celecoxib with other medications before administration
  • Ensure adequate water flushing (30 mL before, between, and after each medication)
  • Administer medications individually
  • Consider that liquid formulations may contain sorbitol, which can cause diarrhea, but this is not an issue with opened capsules mixed with water

The evidence strongly supports opening Celebrex capsules for feeding tube administration when proper technique is followed, with equivalent bioavailability and no compromise to therapeutic efficacy.

References

Research

Stability of celecoxib oral suspension.

The Canadian journal of hospital pharmacy, 2009

Research

Medication administration through enteral feeding tubes.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 2008

Guideline

espen guideline on home enteral nutrition.

Clinical Nutrition, 2020

Guideline

nsaid prescribing precautions.

American family physician, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.